سعر دارزالكس 400 مجم/20مل فيال 2024

Darzalex 400mg/20ml vial: Daratumumab (Janssen cilag > soficopharm).

• Treatment of adult patients with multiple myeloma in combinations or as monotherapy as specified in the US DARZALEX IV prescribing information (newly diagnosed and relapsed/refractory settings per label).Population: Adults with multiple myeloma (oncology protocols)DailyMed (U.S. National Library of Medicine)

• History of severe hypersensitivity to daratumumab or any excipients (US DARZALEX).International label, same product · DailyMed (U.S. National Library of Medicine)

• Infusion-related reactions; interference with serological testing (Indirect Coombs); neutropenia/thrombocytopenia; infections including herpes zoster reactivation — prophylaxis as labeled (US DARZALEX).International label, same product · DailyMed (U.S. National Library of Medicine)

• May cause fetal harm (IgG1 monoclonal antibody); advise females of reproductive potential of risk and contraception per US label.International label, same product · DailyMed (U.S. National Library of Medicine)

• Daratumumab: Binds CD38 on myeloma cells and mediates antibody-dependent cellular cytotoxicity, complement-dependent cytotoxicity, and apoptosis.